Hercules Technology Growth Capital, Inc. (HTGC) - 2013 10-K Summary
Business Context and Reporting Period
Company: Hercules Technology Growth Capital, Inc. (HTGC)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2013
Business Model: HTGC is an internally managed, non-diversified, closed-end investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). It specializes in providing senior secured loans, primarily structured debt with warrants, to venture capital-backed companies in technology-related markets (technology, biotechnology, life sciences, and energy/renewables). The company also operates two Small Business Investment Company (SBIC) subsidiaries (HT II and HT III).
Key Financial Metrics
| Metric | 2013 Value | 2012 Value |
|---|---|---|
| Total Assets | $1,221.7 million | $1,123.6 million |
| Total Investments (at value) | $910.3 million | $906.3 million |
| Total Liabilities | $571.7 million | $607.7 million |
| Total Net Assets | $650.0 million | $516.0 million |
| Net Asset Value (NAV) per Share | $10.51 | $9.75 |
| Total Investment Income | $139.7 million | $97.5 million |
| Net Investment Income | $73.1 million | $48.1 million |
| Net Realized Gain on Investments | $14.8 million | $3.2 million |
| Net Unrealized Appreciation | $11.5 million | ($4.5 million) depreciation |
| Net Increase in Net Assets from Operations | $99.4 million | $46.8 million |
| Cash and Cash Equivalents | $268.4 million | $183.0 million |
| Weighted Average Cost of Debt | 6.1% | 6.6% |
| Effective Yield on Debt Investments | 15.9% | 14.4% |
Material Changes vs. Prior Period
- Revenue Growth: Total investment income increased 43% to $139.7 million, driven by a $36.1 million increase in interest income due to new loan originations and increased amortization. Fee income rose 62% to $16.0 million, largely due to fee accelerations from early loan payoffs.
- Profitability: Net investment income grew 52% to $73.1 million. Net increase in net assets from operations more than doubled to $99.4 million, fueled by a significant turnaround in unrealized appreciation ($11.5 million gain vs. $4.5 million loss in 2012) and higher realized gains ($14.8 million vs. $3.2 million).
- Expense Management: Total operating expenses increased 35% to $66.6 million. Interest and fees on borrowings rose to $35.1 million due to the issuance of 2019 Notes and Asset-Backed Notes in 2012. Employee compensation increased to $22.2 million due to staff expansion and higher variable compensation accruals.
- Portfolio Composition: The portfolio remained stable at $910.3 million. Industry concentration shifted slightly, with Drug Discovery & Development at 24.1% and Energy Technology at 18.1%. The weighted average investment grading of debt investments increased (worsened) from 2.06 to 2.20.
- Liquidity: Cash and cash equivalents increased by $85.4 million to $268.4 million. The company had $373.4 million in available liquidity, including $105.0 million in unused borrowing capacity under credit facilities.
Guidance, Outlook, Risks, and Unusual Items
- Dividend Policy: HTGC maintains a variable dividend policy targeting 90-100% of taxable quarterly income. On February 24, 2014, the Board declared a quarterly dividend of $0.31 per share. The company intends to distribute approximately $3.8 million of spillover earnings from 2013 in 2014.
- Capital Resources: The company has $151.0 million in unfunded contractual commitments. It maintains an "At-The-Market" (ATM) equity distribution agreement for up to 8 million shares, though no sales were made in 2013.
- Debt Structure: Outstanding debt includes $225.0 million in SBA debentures (maxed out for SBICs), $170.4 million in 2019 Notes, $89.6 million in Asset-Backed Notes, and $75.0 million in Convertible Senior Notes. The asset coverage ratio was 295.5% (excluding SBA debentures), well above the 200% regulatory requirement.
- Risks:
- Concentration Risk: 67% of the portfolio is concentrated in four industries (Drug Discovery, Energy, Internet Services, Medical Devices).
- Valuation Uncertainty: 74.5% of assets are Level 3 investments valued by the Board of Directors, subject to significant estimation risk.
- Interest Rate Risk: 99% of the loan portfolio is floating rate; rising rates increase income but also borrowing costs.
- SBIC Regulations: Compliance with SBA regulations is critical; failure could limit distributions needed to maintain RIC tax status.
- Unusual Items: The company recognized a $350,000 realized loss on a debt investment placed on non-accrual. Two loans were on non-accrual status at year-end with a fair value of $12.6 million.
Key Facts for Investor Verification
- NAV vs. Market Price: Verify the current trading price of HTGC stock relative to the reported NAV of $10.51 to assess potential discount/premium.
- Dividend Sustainability: Confirm that the $0.31 quarterly dividend is fully covered by taxable income and that the company maintains sufficient cash flow to meet RIC distribution requirements without excessive asset sales.
- Portfolio Quality: Monitor the trend of the weighted average investment grading (currently 2.20) and the specific performance of the two non-accrual loans ($23.3 million cost basis).
- Debt Covenants: Verify continued compliance with asset coverage ratios (200% minimum) and tangible net worth covenants under credit facilities and note indentures.
- Unfunded Commitments: Assess the company's ability to fund the $151.0 million in unfunded commitments using existing cash, operating cash flow, or new capital raises.